Alpha memo: resveratrol exercise animal-to-aged men endpoint boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reframe the alpha to specify that the boundary is between species/population AND endpoint class, not species alone, and identify which axis is the dominant driver of the contrast.
2. Add a third receipt or explicitly state that no matched cross-species endpoint comparison exists; without it, the falsifier ('matched aged men study where skeletal/metabolic endpoints improve under the same isolated intervention') actually tests something Receipt 2 already partially addressed (it found no resveratrol effect on metabolic/inflammatory).
3. Clarify that Receipt 2's null finding is on metabolic/inflammatory endpoints, while Receipt 1's positive finding is on strength/cardiac — these are not the same endpoint class, so the 'update' is that resveratrol+exercise benefits do not transfer across these distinct endpoints in aged men, not that resveratrol fails to translate.
4. Resolve the 'single-component attribution' hedge: both protocols combine resveratrol with exercise, so this is a real limitation rather than a conditional caveat.

Major issues

• The memo frames the cross-receipt boundary around species/population (rats vs aged men) but Receipt 1 is cardiac/strength/performance and Receipt 2 is metabolic/inflammatory — the endpoints differ fundamentally. The 'update' conflates species transfer with endpoint transfer, so the falsifier cannot be matched on a single axis.
• Receipt 1 establishes a positive resveratrol+exercise effect on strength/cardiac/performance in rats; Receipt 2 tests resveratrol+exercise on metabolic/inflammatory endpoints in aged men. Without a receipt measuring the same endpoint across species, the 'anchor may not transfer' claim is under-specified.

Minor issues

• Receipt 2 excerpt reports a cut-off '3-hydrox' likely referring to 3-hydroxyacyl-CoA dehydrogenase; the bundle excerpt is truncated but consistent with full text.
• Title says 'animal-to-aged men endpoint boundary' which is reasonably descriptive but could clarify whether the boundary is species or endpoint class.
• The 'single-component attribution if a receipt tests a combined protocol' caveat in limitations is hedge-like and should be resolved: both receipts test resveratrol+exercise combined, so attribution ambiguity is a genuine confounder, not a conditional.

Reviewer note

The memo identifies a reasonable cross-receipt boundary between an animal resveratrol+exercise study (positive on strength/cardiac) and a human resveratrol+exercise study in aged men (null on metabolic/inflammatory). The source grounding is solid — both DOIs resolve to appropriate primary studies with excerpts that support the cited claims. The research question is specific and the falsifier is concrete. However, the memo's central tension is that the two receipts differ on TWO axes simultaneously: species/population AND endpoint class. The 'update' claims that the same anchor may not transfer, but Receipt 1's anchor is strength/cardiac while Receipt 2's is metabolic/inflammatory. These are different endpoints in different tissues (cardiac vs skeletal, though both are muscle). The memo partially acknowledges this in 'Bounded contrast' but the synthesis does not clearly resolve whether the species or the endpoint class drives the contrast. The limitations section correctly notes that the pair cannot isolate which axis drives the split, but this means the core 'alpha' — that resveratrol+exercise fails to transfer to aged men — is only partially supported. Receipt 2 actually tests metabolic/inflammatory endpoints, not strength/cardiac, so the memo cannot conclude that resveratrol fails to transfer strength/cardiac benefits to aged men. It can only conclude that metabolic/inflammatory benefits do not transfer. The falsifier is also slightly misaligned: it asks for a matched aged men study showing skeletal/metabolic improvement, but Receipt 2 already tests that and finds null for resveratrol (though exercise alone improves). A cleaner falsifier would specify a matched aged men study testing strength/cardiac endpoints under resveratrol+exercise. Recommend revise: the memo is salvageable with a clearer specification of which axis (species vs endpoint class) carries the contrast, and a reframing of the falsifier to match a genuinely open question rather than one already addressed by Receipt 2.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis